Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations

• Published in: International journal of molecular sciences 2022-12, Vol.24 (1), p.375
• Main Authors: Bai, Yuwen, Cao, Kui, Zhang, Ping, Ma, Jianqun, Zhu, Jinhong
• Format: Article
• Language: English
• Subjects: Adenocarcinoma of Lung - immunology; Carcinogenesis; Carcinoma, Non-Small-Cell Lung - immunology; FAM72A; Humans; LUAD; Lung Neoplasms - immunology; Membrane Proteins; Neoplasm Proteins; pan-cancer; Prognosis; tumor microenvironment
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24010375

The family with sequence similarity 72 Member A (FAM72A) is overexpressed in several types of cancer. However, its contributions to tumorigenesis remain largely unknown. Based on The Cancer Genome Atlas (TCGA) database, FAM72A was upregulated across 33 types of cancer. Accordingly, high levels of FAM72A predicted inferior outcomes in half of the cancer types using survival analysis (the Kaplan-Meier curve and univariate Cox regression model). Receiver operating characteristic (ROC) analysis demonstrated that FAM72A showed high accuracy in distinguishing cancerous tissues from normal ones. FAM72A was correlated with immune and stromal scores and immune cell infiltrations in various tumors. Moreover, FAM72A was also associated with tumor mutation burden (TMB), microsatellite instability (MSI), and immune checkpoint genes. Immunophenoscore (IPS) further validated that the FAM72A tumor showed high immunogenicity and tended to respond to anti-PD1/PDL1/PDL2, anti-CTLA4 treatment, and combined immunotherapies. We also investigated the functional role of FAM72A in lung adenocarcinoma (LUAD). In vitro studies demonstrated that the ectopic expression of FAM72A accelerated the proliferation and migration of NSCLC cells, whereas silencing FAM72A showed the opposite effects on them. In short, FAM72A had prognostic potential and correlated with tumor immunogenicity in various tumors. Functional analysis indicated that FAM72A is an oncogene in LUAD.